Norges Bank’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,133,627
| Closed | -$59.5M | – | 2216 |
|
|
2020
Q3 | $59.5M | Sell |
1,133,627
-490,274
| -30% | -$20.3M | 0.02% | 750 |
|
|
2020
Q2 | $54M | Sell |
1,623,901
-555,170
| -25% | -$17.7M | 0.02% | 787 |
|
|
2020
Q1 | $59.3M | Sell |
2,179,071
-33,094
| -1% | -$921K | 0.02% | 624 |
|
|
2019
Q4 | $43.6M | Buy |
2,212,165
+50,000
| +2% | +$800K | 0.01% | 1006 |
|
|
2019
Q3 | $28M | Buy |
2,162,165
+84,961
| +4% | +$1.03M | 0.01% | 1254 |
|
|
2019
Q2 | $25.9M | Buy |
2,077,204
+223,735
| +12% | +$2.97M | 0.01% | 1341 |
|
|
2019
Q1 | $26.9M | Buy |
1,853,469
+71,479
| +4% | +$913K | 0.01% | 1292 |
|
|
2018
Q4 | $19.7M | Buy |
1,781,990
+718,672
| +68% | +$10M | 0.01% | 1412 |
|
|
2018
Q3 | $28M | Buy |
1,063,318
+99,294
| +10% | +$2.68M | 0.01% | 1313 |
|
|
2018
Q2 | $19.7M | Buy |
964,024
+129,308
| +15% | +$2.77M | 0.01% | 1540 |
|
|
2018
Q1 | $15.2M | Sell |
834,716
-1,284,168
| -61% | -$21.4M | 0.01% | 1586 |
|
|
2017
Q4 | $29.6M | Buy |
2,118,884
+129,775
| +7% | +$1.75M | 0.01% | 1197 |
|
|
2017
Q3 | $36.8M | Buy |
1,989,109
+69,558
| +4% | +$1.16M | 0.01% | 988 |
|
|
2017
Q2 | $32.4M | Buy |
1,919,551
+343,587
| +22% | +$5.23M | 0.01% | 1053 |
|
|
2017
Q1 | $21M | Buy |
1,575,964
+70,970
| +5% | +$1.11M | 0.01% | 1356 |
|
|
2016
Q4 | $22.6M | Hold |
1,504,994
| – | – | 0.01% | 1229 |
|
|
2016
Q3 | $16.8M | Buy |
1,504,994
+100,000
| +7% | +$1.18M | 0.01% | 1345 |
|
|
2016
Q2 | $15.2M | Buy |
1,404,994
+249,112
| +22% | +$2.57M | 0.01% | 1371 |
|
|
2016
Q1 | $10.7M | Hold |
1,155,882
| – | – | 0.01% | 1526 |
|
|
2015
Q4 | $17.2M | Hold |
1,155,882
| – | – | 0.01% | 1258 |
|
|
2015
Q3 | $19M | Hold |
1,155,882
| – | – | 0.01% | 1160 |
|
|
2015
Q2 | $26.4M | Buy |
1,155,882
+100,000
| +9% | +$1.99M | 0.01% | 1019 |
|
|
2015
Q1 | $16M | Hold |
1,055,882
| – | – | 0.01% | 1342 |
|
|
2014
Q4 | $12.7M | Buy |
1,055,882
+547,681
| +108% | +$6.26M | 0.01% | 1520 |
|
|
2014
Q3 | $5.76M | Sell |
508,201
-327,695
| -39% | -$3.74M | ﹤0.01% | 1869 |
|
|
2014
Q2 | $10.1M | Buy |
835,896
+417,948
| +100% | +$4.94M | ﹤0.01% | 1943 |
|
|
2014
Q1 | $4.87M | Hold |
417,948
| – | – | ﹤0.01% | 1898 |
|
|
2013
Q4 | $7.39M | Hold |
417,948
| – | – | ﹤0.01% | 1734 |
|
|
2013
Q3 | $6.01M | Buy |
417,948
+68,918
| +20% | +$1.05M | ﹤0.01% | 1824 |
|
|
2013
Q2 | $5.26M | Buy |
+349,030
| New | +$4.61M | ﹤0.01% | 1820 |
|
Norges Bank's MNTA Position: Q4 2020 in Review
Norges Bank sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,133,627 shares — an estimated $59.5M sold.
Norges Bank first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $59.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Norges Bank reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Norges Bank sold 1,133,627 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $59.5M.
- Norges Bank first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Norges Bank's Momenta Pharmaceuticals, Inc. position peaked at $59.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.